Find More Contacts for Genomatica
Protected Content
Chairman
Executive Management
2 emails found 1 phone number found
View contacts for Genomatica to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@genomatica.com
  • Phone Number (858) 824-1771

Genomatica develops biobased process technologies that enable a better way to produce widely-used chemicals, from alternative feedstocks, with better economics, sustainability, and performance. Genomatica has earned widespread acclaim for its technology; has commercialized processes for the chemical butanediol (for biodegradable plastics and

apparel) and for butylene glycol (cosmetics and personal care), and is working on bio-nylon. Awards include the Kirkpatrick Award, for “the most noteworthy chemical engineering technology commercialized in the world” and the ICIS Innovation Award for its Brontide(TM) butylene glycol.

Lists Featuring This Company

Western US Renewable Energy Companies
2,161 Number of Organizations • $87.6B Total Funding Amount • 2,364 Number of Investors
West Coast Companies With Less Than $1B in Revenue (Top 10K)
9,887 Number of Organizations • $958.2B Total Funding Amount • 85,415 Number of Investors
West Coast Renewable Energy Companies
1,433 Number of Organizations • $69.6B Total Funding Amount • 1,915 Number of Investors
Mohr Davidow Ventures Portfolio Companies
139 Number of Organizations • $16.7B Total Funding Amount • 989 Number of Investors

Frequently Asked Questions

Where is Genomatica's headquarters? Genomatica is located in San Diego, California, United States.Who invested in Genomatica? Genomatica has 18 investors including Lululemon and Novo Holdings.How much funding has Genomatica raised to date? Genomatica has raised .When was the last funding round for Genomatica? Genomatica closed its last funding round on Aug 18, 2021 from a Corporate Round round.Who are Genomatica's competitors? Alternatives and possible competitors to Genomatica may include Blue OriginBeta Technologies, and Amyris.